{"version":"1.0","type":"link","title":"Targeting PLK1 potentiates the antitumor efficacy of EGFR-TKIs through inhibiting the JAK1/STAT3 pathway.","author_name":"Li C 외","author_url":"https://prs-insight.online/author/Li%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98609","thumbnail_width":1200,"thumbnail_height":630}